OnKure Therapeutics, Inc. (NasdaqGM: OKUR)
Health Care · Biotechnology · US
$3.85
-3.51% today · +42.5% 1Y
OnKure Therapeutics, Inc. (NasdaqGM: OKUR) operates in the Biotechnology industry within the Health Care sector. The company is valued at $161.58M and employs 45 people.
Over the last twelve months the share price has gained 42.5%, trading between 1.91 and 5.38.
Tweenvest scores OnKure Therapeutics, Inc. across four factors: quality 26/100. Its strongest factor is quality.
OKUR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $161.58M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -2.58
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $5.38
- 52-week low
- $1.91
- Avg volume (3M)
- —
- Shares outstanding
- 40.50M
- Employees
- 45
- Next earnings
- —
About OnKure Therapeutics, Inc.
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.
- ISIN
- US68277Q1058
- Founded
- 2011
- Listed since
- Apr 8, 2021
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.83 | +14.36% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.